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Introduction
Orthostatic hypertension is an increase in blood pressure 
(BP) in the erect position from that measured in the seated 
or supine position. The subject of orthostatic hypertension 
(unlike orthostatic hypotension which is well known) is 
seldom discussed and so there is a relative dearth of 
literature on it. There appears to be no conventional 
definition of orthostatic hypertension at the moment, 
therefore most of the definitions have been operational 
within study designs. However, what is consistent among 
these definitions is the increase in BP in the erect position. 
Orthostatic hypertension has attracted attention largely 
because the few available studies have associated it with 
diverse clinical conditions such as essential hypertension, 
silent intracerebral infarcts, cognitive decline, type 2 
diabetes mellitus and increased target organ damage 
in individuals who are hypertensive. Although the exact 
pathophysiology of orthostatic hypertension has not yet 
been elucidated completely, overcompensation of the 
sympathetic alpha adrenergic baroreflex mechanism 
response to the haemodynamic effect of the erect posture 
is believed to be central to it. 
In this preliminary study, we describe the basic 
characteristics of orthostatic hypertension in a cohort of 
hypertensive Nigerians.
Method
One hundred and seventy-nine (179) patients on follow-up 
treatment in a hypertension clinic at the Federal Medical 
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Centre, Owo, a semi-urban setting in south-west Nigeria, 
were consecutively assessed for demographic variables 
of age, sex, occupation and domicile, and for BP in the 
seated position and after two minutes in the erect position 
on three consecutive visits over a period of 12 weeks, 
regardless of the antihypertensive medication they were 
on. BP was recorded manually with a standard Accoson® 
mercury sphygmomanometer between the hours of 09h00 
and 12h00 by one of the investigators. The left arm was 
used, and the sphygmomanometer mercury column was 
placed at arm level, in both the seated and erect positions, 
to mitigate the effect of posture and gravity. The time 
interval between the two positions was determined with a 
stopwatch. All the study participants were asked to empty 
their bladders and rest for at least 30 minutes prior to the BP 
checks. Potential stimulants, such as coffee and cigarette 
smoking, were avoided on the day of evaluation. Orthostatic 
hypertension was defined as an increase in systolic blood 
pressure (SBP) of ≥ 20 mmHg in the erect position on more 
than one occasion. Orthostatic hypotension was defined 
as a decrease in BP between seated and erect SBP of 
≥ 20 mmHg on more than one occasion.   
Exclusion criteria for the study were clinically manifested 
renal failure, or a serum creatinine level of above 2 mg/dl, 
systemic corticosteroid therapy and diabetes mellitus. The 
study was approved by the ethics committee (Institutional 
Review Board) of the Federal Medical Centre, Owo.  
Statistics
Mean age, sex distribution, prevalence of orthostatic 
hypertension and orthostatic hypotension were described 
in a frequency table (see Table I). Orthostatic hypertension 
was computed as the mean of the orthostatic increases in 
BP ≥ 20 mmHg, and orthostatic hypotension as the mean of 
the orthostatic decreases in BP ≥ 20 mmHg. The mean ages 
of the participants with and without orthostatic hypertension 
were compared by means of an independent t-test for any 
significant differences. The mean of the seated SBPs of the 
participants with and without orthostatic hypertension were 
also compared with an independent t-test. The mean of the 
seated and erect BPs of the participants with and without 
orthostatic hypertension were compared with a paired 
t-test for any significant differences. The effect of gender 
on orthostatic hypertension was tested with a chi-square 
(χ²). Analyses were done with IBM® SPSS version 16, and 
p-value ≤ 0.05 was taken as significant.
Results
The lower mean seated SBP of the participants with 
orthostatic hypertension compared to the participants 
without orthostatic hypertension is noted, and suggests 
that an orthostatic increase can occur regardless of the 
seated BP.
The preponderance of participants without orthostatic 
hypertension compared to those with orthostatic 
hypertension is shown in Figure 1. 
No significant difference was found between the mean 
ages, as shown in Table II.
Table II: The independent t-test results of the mean ages of the 
participants with and without orthostatic hypertension
 Levene’s test for 
equality of variances










1.169 0.281 0.268 177 0.789
No significant effect of gender was found on orthostatic 
hypotension, as is shown in Table III.









Number of valid cases 179





Number of participants (n)/total 38/179 141/179






Sex (female/male) 24/14 83/58










Number with orthostatic 
hypotension (%)
Not applicable 5 (2.79%)
a = standard deviation















Figure 1: Bar chart showing the distribution of participants with and 
without orthostatic hypertension
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The significant differences between the means of the seated 
SBPs are shown in Table IV.
The significant differences between the means of the 
seated and erect SBPs of the participants with orthostatic 
hypertension are shown on paired t-test statistics in Table V.
No significant differences were found between the mean of 
the seated and erect SBPs on a paired t-test in participants 
without orthostatic hypertension (see Table VI).
Discussion
Orthostatic hypertension  is the increase in BP that arises 
when assuming an erect position, after having had a 
BP measurement taken while in the seated or supine 
position. On assuming an erect position, BP normally drops 
insignificantly due to the effect of microgravity, which causes 
the pooling of about 10% of the blood volume in the lower 
extremities.1 Following orthostasis, the resultant decrease 
in the thoracic blood volume excites the baroreceptor 
sympathetic mechanisms to compensate for the volume 
reduction with an increase in the heart rate and peripheral 
vascular resistance; the effect of which is a negligible 
decrease in BP in healthy individuals.1,2 With orthostatic 
hypertension, there is a significant increase in the BP on 
assuming the erect position, due partly to baroreceptor 
overcompensation, although the exact pathophysiology is 
not yet completely clear.3 Because the orthostatic increase 
in BP could be abolished with alpha adrenergic blocking 
agents, alpha adrenergic activity has been implicated as the 
predominant pathophysiological mechanism of orthostatic 
hypertension.4 At present, there is no standard definition 
of orthostatic hypertension with regard to the margin of BP 
increase, and as such, the only available definitions have 
been operational within study designs. Although the clinical 
significance of orthostatic hypertension in hypertensives 
is still not fully known, it has been associated with diverse 
clinical conditions, ranging from silent cerebral infarcts, 
and cognitive decline, to target organ damage.5,6 In 
normotensive subjects, orthostatic hypertension has been 
found to be highly predictive of essential hypertension, so 
much so that it has been described as a prehypertension 
state.7 Like isolated systolic hypertension and orthostatic 
hypotension, orthostatic hypertension has generally 
been associated with the elderly, early-stage neuropathy 
and sustained hypertension in type 2 diabetes, morning 
hypertension, increased neurohumoral activity, and greater 
cardiac burden in hypertensive patients.6,7,8 
In this study, we noted that the mean age of those with 
orthostatic hypertension did not differ significantly from 
those without orthostatic hypertension (61  ±  14.17 vs. 
60.38  ±  12.13, p-value  =  0.789). The gender distribution 
of participants with and without orthostatic hypertension 
showed a similar trend of female preponderance (24 vs. 
14, n = 38 and 83 vs. 58, n = 141). Thirty-eight (21.22%) 
of the 179 participants who were studied had orthostatic 
hypertension. A similar study found an 11% prevalence.3 
In a related population-based study on the prevalence 
and correlates of orthostatic hypotension and orthostatic 
hypertension, none of the participants under the age of 
40 years had orthostatic hypertension. The prevalence of 
orthostatic hypertension was 1.1%, and age was found 
to correlate significantly with orthostatic hypertension.9 
Another population-based study found a prevalence as 
high as 30%, but this might reflect the difference in the 
design of the studies, particularly in terms of the definition 
of orthostatic hypertension.10 The prevalence of orthostatic 
hypertension in this study might have been influenced 
by antihypertensive medications, particularly the alpha 
adrenergic receptor blockers.4 
Table IV: Independent t-test results comparing the means of the seated 
SBP of the orthostatic hypertension and non-orthostatic hypertension 
participants
 Levene’s test for 
equality of variances











0.215 0.643 -2.685 177 0.008
a = systolic blood pressure
Table V. Paired t-test results of the means of the seated and erect SBPs of participants with orthostatic hypertension 
Paired differences (mean) Standard deviation T-test Degrees of freedom Significance (two-tailed)
Seated aSBP
Erect SBP
-21.3158 3.4257 -38.357 37 0.000
a = systolic blood pressure
Table VI. Paired t-test results of the mean of the seated and erect SBPs of participants without orthostatic hypertension
Paired differences (mean) Standard deviation T-test Degrees of freedom Significance (two-tailed)
Sitting aSBP
Standing SBP
-0.9929 8.5210 -1.384 140 0.169
a = systolic blood pressure
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The contribution of gender to orthostatic hypertension was 
also not significant (χ² = 0.459, p-value = 0.795). Although 
orthostatic intolerance has been associated with women 
more than with men, a related study involving angiotensin-
converting enzyme (ACE) genetics in orthostatic 
hypertension found no difference between males and 
females with regard to orthostatic hypertension rates.11,12 
Remarkably, the mean seated SBP of the participants with 
orthostatic hypertension was significantly lower than that 
of those without orthostatic hypertension (p-value = 0.008), 
and the difference between the mean seated and erect SBPs 
in participants with orthostatic hypertension, compared to 
those without orthostatic hypertension, shown on paired 
t-test statistics, was also significant (p-value  =  0.000 vs. 
p-value = 0.169). These results suggest that there can be 
significant orthostatic increases, even at normotensive levels 
of BP. They may also suggest that unless an orthostatic 
increase in BP is routinely investigated, this form of BP 
dysregulation may be missed, particularly in hypertensives 
with controlled BP. Only five participants, representing 
2.79% of the total sample, had orthostatic hypotension.    
We recognise the fact that the participants were exposed 
to diverse classes of antihypertensive medications and that 
these might have had a possible influence on the changes 
in orthostatic BP, and in particular, the alpha adrenergic 
blockers. It bears reiteration that orthostatic hypertension 
is in dire need of research, both in the elucidation of its 
exact pathophysiology and clinical significance, and also 
with regard to a consensus definition to enable comparative 
studies across different population groups. We conclude 
that orthostatic hypertension may be more common among 
hypertensives than previously thought, and as knowledge of 
this seldom-discussed form of BP dysregulation increases, 
it may influence the choice of antihypertensive drugs in the 
near future. 
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